Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

BACKGROUND: Safe and effective vaccines against coronavirus disease 2019 (Covid-19) are urgently needed in young children. METHODS: We conducted a phase 1 dose-finding study and are conducting an ongoing phase 2–3 safety, immunogenicity, and efficacy trial of the BNT162b2 vaccine in healthy children...

Descripción completa

Detalles Bibliográficos
Autores principales: Muñoz, Flor M., Sher, Lawrence D., Sabharwal, Charu, Gurtman, Alejandra, Xu, Xia, Kitchin, Nicholas, Lockhart, Stephen, Riesenberg, Robert, Sexter, Joanna M., Czajka, Hanna, Paulsen, Grant C., Maldonado, Yvonne, Walter, Emmanuel B., Talaat, Kawsar R., Englund, Janet A., Sarwar, Uzma N., Hansen, Caitlin, Iwamoto, Martha, Webber, Chris, Cunliffe, Luke, Ukkonen, Benita, Martínez, Silvina N., Pahud, Barbara A., Munjal, Iona, Domachowske, Joseph B., Swanson, Kena A., Ma, Hua, Koury, Kenneth, Mather, Susan, Lu, Claire, Zou, Jing, Xie, Xuping, Shi, Pei-Yong, Cooper, David, Türeci, Özlem, Şahin, Uğur, Jansen, Kathrin U., Gruber, William C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947923/
https://www.ncbi.nlm.nih.gov/pubmed/36791162
http://dx.doi.org/10.1056/NEJMoa2211031

Ejemplares similares

Ejemplares similares